Eastman Chemical (EMN) Tops Q1 EPS by 24c, Revenue Misses, Comments on Outlook

Eastman Chemical (NYSE: EMN) reported Q1 EPS of $1.84, $0.24 better than the analyst estimate of $1.60. Revenue for the quarter came in at $2.44 billion versus the consensus estimate of $2.56 billion.

Commenting on the outlook for full year 2015, Costa said: “Our outlook since January has improved as our first quarter year over year earnings growth demonstrates that we are benefitting from strong leadership positions in key markets, the diversity of end-markets and geographies we serve, and improved product mix from market adoption of our specialty products. We face increasing challenges including global economic uncertainty, the strengthening U.S. dollar, and the impact of volatile oil prices. Given our strong start to the year, expectations for solid volume growth in our specialty businesses and continued strong results from recent acquisitions, as well as our discipline in managing costs, we are now well positioned for our sixth consecutive year of EPS growth. We also continue to expect strong cash flow generation.” Non-core and non-recurring items are excluded from the earnings per share projection.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• XP Inc. (XP) Tops Q2 EPS by 8c
• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown